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The antioxidant activities of 53 medicinal plants used in Bamun Folk Medicine for the management of 
jaundice and hepatitis were investigated. The studies were done using rat hepatic microsomes for lipid 
peroxidation and bovine serum albumin (BSA) for carbonyl group formation. Silymarine was used as reference 
compound. Fifteen different extracts were effective at a dose of 200µg/ml in both experiments. Specifically, 25 
extracts inhibited lipid peroxidation initiated non-enzymatically by ascorbic acid while 18 inhibited 
peroxidation as determined by reduced Nicotinamide Adenine Dinucleotide Phosphate (NADPH). The 
inhibitory concentration 50 (IC50) of 23 different plant extracts was lower than 200µg/ml in the microsomal 
lipid peroxidation inhibition study. Fifteen of the 23 extracts were active in preventing protein oxidation by 
inhibiting the formation of the carbonyl group on BSA with an IC50 value less than 200µg/ ml. The results 
suggest that the antioxidant activity of the extracts, may be due to their ability to scavenge free radicals involved 
in microsomal lipid peroxidation or in protein oxidation. These biochemical processes are involved in the 
aetiology of toxic hepatitis. 
 





Lipid peroxidation and protein oxidation are reported to be involved in the aetiology of several human 
diseases such as atherosclerosis, ischemia-reperfusion injury, ageing, and liver-related diseases (Dean et al., 
1997; Aruoma, 1998). In paracetamol- and CCl4-induced hepatitis particularly, the most widely used animal 
models for the study of the hepatocurative or preventive effect of many medicinal plants (Lin et al., 1995; 
Shenoy et al., 2001; James et al., 2003), lipid peroxidation and protein oxidation play the main role in the 
development of the disease (Recknagel, 1983; Fleurentin and Joyeux, 1990; Vuletich and Osawa, 1998; 
Michael et al., 1999). Thus, the inhibition of these oxidation phenomena may be important for the alleviation of 
the resulting diseases. 
In the Bamun folk medicine, quite a number of plants are reported to be used for the treatment of 
hepatitis and other liver related-diseases (Mongbet, 1975, Moundipa et al., 2001). However, for a good number, 
no report is available to prove their therapeutic activity. Since toxic hepatitis is often associated with the 
oxidative destruction of lipids and proteins, the plants used by the Bamun in order to alleviate liver-related 
diseases may contain compounds which protect lipids and proteins from oxidation since such compounds have 
been suggested as prophylactic agents (Aruoma, 1997). 
                                                 
 









Therefore, the present work was aimed at identifying among these plants, those that are potentially 
active in the protection of biomolecules of the liver and other organs against oxidation. Thus, the inhibitory 
effect of their respective extracts on the course of lipid peroxidation induced non-enzymatically or 
enzymatically in rat liver microsomes has been assessed. We also assayed the inhibitory action of these extracts 
on the hydroxyl-mediated oxidation of bovine serum albumin (BSA). 
 
Materials and Methods 
 
Chemicals:  All reagents used in this study were purchased from Sigma Chemicals Company (St. Louis, MO, 
USA) and Prolabo (Paris, France).  
Plant extracts:  Fifty-four plants were used in this study, selected according to a previous survey carried out in 
the Bamun region (Moundipa et al., 2002). The parts used were either the bark, the leaves, tubers or rhizomes. 
The air-dried and powdered parts (50g) of each plant were extracted by maceration with a mixture of methanol-
methylene chloride (200ml, v/v) for 24 hrs with constant shaking. The plant extracts were evaporated to dryness 
under vacuum, the yield computed and the residue kept at –40°C for pharmacological studies. 
 
Screening of lipid peroxidation and protein inhibitory activities  
Lipid peroxidation assay  
 
Male Wistar rats weighing 180 – 200g were sacrificed by cerebral dislocation after overnight fasting.  
The liver was removed and homogenised in ice cold 150mM KCl solution.  Liver microsomes were isolated by 
the calcium aggregation procedure as described by Garle and Fry (1989). Protein concentration in the 
microsomal suspension was assayed by the Bradford method (Bradford, 1976) using BSA as standard.  The 
resulting suspension was diluted to 10mg of microsomal protein/ml in buffer (25mM Tris-HCl, 115mM KCl, 
pH 7.5), and stored at –40°C. Experiments were carried out according to the method described by Ulf et al., 
(1989). Silymarine and plant extract concentrations were tested at 10, 100 and 200µg/ml. Lipid peroxidation 
was initiated non-enzymatically using ascorbate or enzymatically by NADPH (only for plant extracts for which 
IC50 was less than 200µg/ml). The reaction mixture consisted of microsomes (0.4mg protein/ml), plant extract 
and 0.5mM ascorbate or 0.3mM NADPH in 25mM Tris-HCl buffer, pH 7.5 containing 115mM KCl. The 
reaction was initiated by the addition of 1.5µM Fe2+ (in the form of (NH4)2Fe(SO4)2) complexed with 1mM 
ADP. After the incubation period (15 min, 37°C), the reaction was stopped by the addition of thiobarbituric acid 
reagent. The samples were then assayed for thiobarbituric acid-reactive substances (TBA-RS) as described by 
Wills (1987). Lipid peroxidation was expressed as the change in absorbance of TBA-RS at 530nm. The amount 
of TBA-RS which existed in the mixture before the peroxidation reaction was substracted from the value 
obtained. 
 
BSA oxidation assay 
 
 BSA was oxidised by a Fenton-type reaction (Martinez et al., 2001). The reaction was carried out in 
2ml polypropylene tubes with lids. Plant extracts were added to the medium and, after incubation and protein 
precipitation by TCA, the mixture was centrifuged (3000g, 4°C, 5 min) and the pellet used for protein carbonyl 
content determination. This was assayed as a 2,4-dinitrophenylhydrazine (DNPH) derivative by of the method 
described by Martinez et al., (2001) with some modifications. After extraction and a second precipitation of the 
precipitate, the protein pellets were dissolved in 1ml of 6M urea and centrifuged (3000g, 4°C, 5 min). The 




Groups of phytochemical compounds (flavonoids, polyphenols, leucoanthocyanins, alkaloids, tannins, 
triterpens and sterols, anthranoids) were tested for their presence in each extract using commonly accepted 




Different IC50 values were estimated using the EPA probit analyses, on computer program version 1.3 
used by C. Stephen of the Duluth USEPA, Research Laboratory. 
 
 







Lipid peroxidation and protein inhibitory activities of extracts 
Inhibition of microsomal lipid peroxidation 
 
The respective inhibition percentages (IP) obtained for each extract are shown in Table 1. These values 
varied considerably for the different plant extracts. For each extract, this variation also depended on the mode of 
initiation of peroxidation. Based on the IP, in the non-enzymatical microsomal lipid peroxidation system, at a 
concentration of 200µg/ml, plant extracts with values equal to or above 50 were selected for further experiments 
with the Fe(II)-NADPH system. Twenty-five extracts were thus selected and tested in the system where the 
reaction was sustained by NADPH. Of these, only 18 extracts were active with an IP value above 50 at 
200µg/ml (Table 1). Table 3 presents the IC50 values of different plant extracts according to the mode of 
initiation the lipid peroxidation reaction.  
 
Inhibition of BSA oxidation 
 
 The IP values of hydroxyl-mediated oxidation of BSA are presented in Table 2 and the IC50 in Table 
3. The values of the former varied between different extracts. Only 26 different plant extracts were active above 
50 at 200µg/ml.  
 
Groups of compounds in different plant extracts 
 
The phytochemical studies of plant extracts active in inhibiting microsomal lipid peroxidation or/and 
protein oxidation revealed the presence of flavonoids, polyphenols, alkaloids, among other classes of 





In many traditional practices, there are medicines used for the treatment of liver-related diseases 
(Fleurentin and Joyeux, 1990). These medicines are generally based on medicinal plants and their systematical 
screenings often permit leads to the identification of the effective plants (Joyeux et al., 1990, Lin et al., 1995). 
Extracts of plants under study were tested for their microsomal lipid peroxidation and protein oxidation 
inhibitory activities. On the whole, the active extracts inhibited both biochemical processes in a dose-dependent 
manner. Similar results were obtained by Czinnera et al. (2001) on the action of Helichrysi flos regarding the 
inhibition of microsomal lipid peroxidation.  
In the present study, plant extracts inhibiting both oxidation phenomena with an IC50 less than 
200µg/ml were considered as possessing a high protein and lipid oxidation inhibitory potential. In this respect, 
Mangifera indica, Enantia chlorantha, Voacanga africana, Aspilia africana, Senna alata, Piliostigma 
thonningii (bark), Piliostigma thonningii (leaves), Kalonchoe crenata, Alchornea laxiflora, Crotalaria 
lachnophora, Erythrina senegalensis, Khaya grandifoliola, Entada africana, Melinis minutiflora and Curcuma 
longa (Table 2) were found to be active. Among these active plant species, some of them, namely E. chlorantha 
(Virtanen et al., 1993), E. africana (Sanogo et al., 1998) and C. longa (Pulla and Lokesh, 1994; Sreejayan and 
Rao, 1994; Ruby et al., 1995), have been reported to be active against experimentally induced hepatitis. M. 
indica on its part, has been shown to be very effective against lipid and protein oxidation in vitro and injury 
associated to hepatic ischemia reperfusion (Martinez et al., 2001; Sanchez et al., 2000). Concerning S. alata, the 
choleretic effect of its extract on rats was demonstrated by Assane et al. (1993). 
The protection of the hydroxyl-mediated oxidation of BSA takes place essentially by reducing the 
H2O2 concentration, a fundamental component in Fenton-type reaction, by chelating iron or by scavenging the 
hydroxyl radical formed on the immediate side of the target protein during oxidation (Kingu and Wei, 1997). 
This may suggest that these plant extracts are able to scavenge hydroxyl radical or chelate iron. The inhibitory 
effect against the free radical-mediated degradation of BSA and the microsomal lipid peroxidation by plant 
extracts mentioned above may also be attributed to flavonoids and polyphenols as many of these 
phytoconstituents are known to be antioxidants (Faurè et al., 1990; Markus, 1996; Middleton et al., 2000). The 
presence of these two families of compounds was revealed in all the above cited plant extracts. This is in 
accordance with phytochemical screening done by Noguchi et al. (1994) and Wandji et al., (1994) respectively 





Table 1: Inhibition percentages of microsomal lipid peroxidation of different plants extracts and initiation modes. 
 
Inhibition percentage 
Fe(II)-Ascorbate1 Fe(II)- NADPH1 
Concentrations of plant extracts (µg/mL) Concentrations of plant extracts (µg/mL) 
Species  Family 
10 100 200 10 100 200 
Control silymarine  61.86 ± 2.61 86.81 ± 1.45 99.29 ± 3.23 62.15 ± 1.65 78.79 ± 3.54 99.40 ± 2.65 
Eremomastas  speciosa (hochst.) Cufod  Acanthaceae 5.58 ± 1.23 15.01 ± 1.23  46.16 ± 0.35    
Draceana  deisteliana Engl. Agavaceae -2.63 ± 0.48 -1.72 ± 1.45 -0.46 ± 0.00    
Mangifera  indica Lin.  Anacardiaceae 5.46 ± 0.49 66.75 ± 0.33 75.35 ± 1.32  15.42 ± 1.17 60.56 ± 0.00 77.5 ± 0.40 
Annona  senegalensis Pers.  Anonaceae -3.76 ± 4.96 14.29 ± 0.35 16.17 ± 0.88    
Enantia  chlorantha Oliv.  Anonaceae 33.25 ± 0.71 42.06 ± 0.52 53.97 ± 0.52 12.19±2.34 28.87±0.98 53.87±0.00 
Voacanga africana Stapf  Apocynaceae 57.82 ± 1.05 100.00 ± 0.00 100.00±0.00 53.04±1.18 92.13±2.14 100.00±0.00 
Xanthosoma  sagittifolium L. Schott  Araceae 1.37 ± 053 25.31±0.71 48.01 0.88    
Polyscias fulva (Hiern.) Harms.  Araliaceae -0.02 ± 0.00 -0.04±0.01 -0.01±0.27    
Ageratum conyzoides Lin.  Asteraceae -2.79 ± 1.00 -2.56±3.00 -9.31±3.29    
Aspilia africana (Pers.) C.D. Adams  Asteraceae 18.26 ± 0.37 35.72±0.37 52.91±0.37 32.95±0.54 51.53±0.18 68.45±0.72 
Bidens pilosa Lin.  Asteraceae 14.19±  0.33 39.82±2.91 50.92±1.38 4.86±1.37 33.06±0.39 52.92±0.59 
Chrysanthellum americanum (Lin.) Vatke  Asteraceae 2.91 ± 0.00 22.89±0.19 17.20±1.12    
Dichrocephala integrifolia (Lin.F ) O.Ktze  Asteraceae 1.24 ± 0.35 2.61±0.87 25.43±0.88    
Emilia coccinia (Sims.) G. Don  Asteraceae -7.15 ± 6.20 -5.77±3.19 -1.51±1.77    
Sonchus oleraceus Lin.  Asteraceae -0.75 ± 0.35 -5.71±0.35 31.02±0.35    
Spilanthes filicaulis (Sch. et Th.) C.D. Adams  Asteraceae 9.18 ± 0.35 18.99±1.23 58.93±0.17 0.55±0.00 3.18±0.20 12.29±0.98 
Vernonia amygdalina Del.  Asteraceae 0.93 ± 0.00 26.98±0.33 33.49±1.97    
Dacryodes edulis (G.Don) H.Lam  Burseraceae -0.26 ± 0.00 -6.75±1.68 -8.20±0.00    
Carica papaya Lin.  Caricaceae -3.38 ± 1.15 -4.07±3.78 -2.68±1.80    
Senna alata (Lin.) Link  Cesalpilaceae 34.53 ± 0.94 71.30±0.56 88.50±0.56 46.44±0.18 92.37±0.00 100.00±0.00 
Piliostigma thonningii (Sch.) M. Red.  (L) Cesalpilaceae 32.84 ± 0.16 58.70±0.16 74.26±0.81 35.14±0.59 61.81±0.59 68.47±1.37 
















Table 1 (continued): Inhibition percentages of microsomal lipid peroxidation of different plants extracts and initiation modes. 
Terminalia glaucescens Planch.ex 
benth.  
Combretaceae 2.10 ± 0.66 7.32±0.49 47.68±1.65    
Ipomea batatas (Lin.) Lam  Convolvulaceae 2.10 ± 0.33 5.12±1.65 14.30±0.49    
Kalonchoe crenata (Andr.) Haw. Crasulaceae 17.18 ± 0.76 36.31±0.00 73.70±0.50 11.88±0.39 44.48±0.39 59.81±1.76 
Alchornea laxiflora (benth.) Pax& 
K.H  
Euphorbiaceae 58.07 ± 9.91 84.39±0.75 95.90±0.57 40.84±0.39 65.42±1.77 79.17±1.57 
Manihot esculenta Crantz Euphorbiaceae -1.15 ± 0.64 -0.46±0.00 -4.80±0.00    
Crotalaria lachnophora Hochst.ex 
A.R.  
Fabaceae 22.54 ± 0.76 84.26±0.50 97.41±0.37 38.26±1.37 68.37±1.75 74.45±0.98 
Erythrina senegalensis D.C  Fabaceae 39.32 ± 3.79 75.20±2.12 94.25±0.71 35.91±0.78 61.33±3.91 75.69±0.40 
Harungana  madagascariensis Lam. Hypericaceae 13.60 ± 0.50 71.38±1.01 81.75±0.00 31.08±0.59 67.96±0.39 76.25±0.39 
Gladiolus dalenii Van Geel  Iridaceae -0.36 ± 0.25 -3.94±0.25 -8.23±1.27    
Occimum Gratissimum Lin. Labieae 14.99 ± 0.16 55.38±1.62 68.01±0.49 1.11±0.00 23.89±1.57 43.75±1.37 
Persea  americana Mill.  (L) Lauraceae -6.02 ± 1.77 2.63±3.01 24.31±0.00    
Persea  americana Mill.  (B) Lauraceae 29.52 ± 0.65 29.87±0.16 44.85±4.52    
Anthocleista schweinfurthii Gil. Loganiaceae -0.01 ± 0.01 -0.07±0.01 -0.05±0.01    
Gosypium barbadense (Mac fedyen) 
J.B.H. 
Malvaceae 8.24 ± 1.60 53.32±1.29 56.98±0.33 0.56±0.39 7.78±0.78 40.14±0.98 
Khaya grandifoliola D.C. Meliaceae 1.51 ± 0.49 60.94±0.66 78.91±1.08 12.50±0.00 53.33±0.00 59.87±0.98 
Entada africana (Guill. et Pers.)  Mimosaceae 25.17 ± 0.00 50.34±0.00 82.73±0.49 38.48±0.59 74.03±1.37 100.00±0.00 
Ficus exasperata Vahl.  Moraceae -1.40 ± 0.00 -6.98±3.29 -6.98±0.00    
Ficus sp.  Moraceae -0.01±  0.00 -0.04±0.00 -0.07±0.00    
Musa sapientum Lin.  Musaceae -2.15 ± 2.78 -6.09±0.76 -9.33±1.39    
Eucalyptus sp.   Myrtaceae 50.93±  0.19 78.18±0.94  76.19±0.00 29.77±1.44 65.90±0.00 85.63±0.18 
Psidium guayava Lin.  Myrtaceae 2.21 ± 0.49 14.54±0.83 50.47±2.64 7.08±1.77 24.31±0.98 32.92±1.38 
Olax subscorpioideae Oliv.  Olacaceae 18.26 ± 0.37 42.86±0.00 44.71±0.00    
Cymbopogon citratus ( D.C.) Stapf  Poaceae -1.25 ± 1.10 -5.71±0.35 -9.66±0.38    
Melinis minutiflora P. Bearw  Poaceae 32.67 ± 1.68 86.11±0.93 58.47±0.37 10.56±0.54 61.32±0.72 71.33±0.90 
Coffea arabica Lin.  Rubiaceae 39.69 ± 1.12 25.00±1.32 10.05±0.00    
Coffea robusta lin.  Rubiaceae 8.27 ± 0.35 19.43±7.62 41.23±1.60    
Nauclea latifolia Sm.  Rubiaceae 25.97 ± 1.13 33.41±0.33 43.02±1.61    
Citrus aurantifolia Swingle  Rutaceae 1.61 ± 0.18 26.31±0.71 54.59±1.40 11.74±058 20.31±0.59 30.80±4.10 
Citrus sinensis L. ( Osbeck ) Rutaceae 15.01±  1.23 54.71±0.52 100.00±0.00 12.57±0.59 24.72±0.98 46.83±2.54 
Solanum acaleastrum Dunal  Solanaceae 11.00 ± 1.00 40.23±7.62 28.57±0.00    
Trema orientalis Lour.  Ulmaceae -1.28 ± 1.15 -2.91±0.81 -5.23±4.77    
Costus afer Ker .Gawl  Zingiberaceae 7.51 ± 0.00 25.31±0.38 68.16±2.02 0.83±0.00 2.62±0.98 11.61±3.51 
Curcuma longa Lin.  Zingiberaceae 53.26 ± 1.95 77.44±0.35 90.36±0.18 91.60±0.00 100.00±0.00 100.00±0.00 
1-Initiation mode of lipid peroxidation: Fe (II)-Ascorbate (non-enzymatical lipid peroxidation), Fe (II)-NADPH (enzymatical lipid peroxidation), Data are given as 
mean ± SD of two experiments;    L = Leaves;      B = Stem bark






Table 2: Inhibition percentages of carbonyl-group formation of different plants extracts 
 
Inhibition Percentage   Species Family 
Fe(III)-EDTA / H2O2 / Ascorbate1 
Concentration of plant extracts (µg/ml) 
  10 100 200 
Control silymarine  51.19 ± 2.34 84.18 ± 4.54 99.40 ± 3.56 
Eremomastas speciosa (hochst.) Cufod  Acanthaceae 9.52±0.00 31.79±0.00 45.03±0.00 
Draceana deisteliana Engl  Agavaceae 5.07±0.35 16.55±0.76 38.27±1.30 
Mangifera indica Lin.  Anacardiaceae 69.47±0.27 89.44±0.15 99.21±0.00 
Annona senegalensis Pers.  Anonaceae 44.49±1.63 68.59±3.23 85.17±0.82 
Enantia chlorantha Oliv.  Anonaceae 20.67±1.44 44.95±0.57 61.62±0.72 
Voacanga africana Stapf  Apocynaceae 24.80±1.29 36.34±0.71 76.75±0.59 
Xanthosoma sagittifolium L. Schott  Araceae -0.81±0.30 14.50±1.56 29.58±0.30 
Polyscias fulva (Hiern.) Harms.  Araliaceae 5.00±0.45 27.40±1.48 42.89±0.31 
Ageratum conyzoides Lin.  Asteraceae 34.13±0.15 35.24±0.33 48.71±0.42 
Aspilia africana (Pers.) C.D. Adams  Asteraceae 59.39±3.24 81.63±1.00 86.33±0.81 
Bidens pilosa Lin.  Asteraceae 5.81±0.26 15.68±0.12 33.24±1.83 
Chrysanthellum americanum (Lin.) Vatke  Asteraceae 61.09±1.90 88.02±0.00 99.58±0.59 
Dichrocephala integrifolia (Lin.F ) O.Ktze  Asteraceae 2.74±0.45 19.44±0.27 42.92±0.00 
Emilia coccinia (Sims.) G. Don  Asteraceae 14.01±2.59 29.59±3.23 35.22±1.46 
Sonchus oleraceus Lin.  Asteraceae 4.46±1.44 4.46±0.00 22.16±2.14 
Spilanthes filicaulis (Sch. et Th.) CD. Adams  Asteraceae 5.27±0.30 12.56±1.41 42.41±0.72 
Vernonia amygdalina Del.  Asteraceae 27.83±1.44 58.77±1.47 75.27±1.47 
Dacryodes edulis (G.Don.) H.Lam  Burseraceae 9.10± 0.00 26.68±3.76 47.20±1.10 
Carica papaya Lin.  Caricaceae 32.89±1.32 71.66±0.70 87.20±0.60 
Senna alata (Lin.) Link  Cesalpilaceae 70.05±1.16 84.38±0.30 98.94±0.48 
Piliostigma thonningii (Sch.) M. Red.  (L) Cesalpilaceae 61.38±0.68 71.36±0.69 91.81±0.26 
Piliostigma thonningii (Sch.) M. Red.  (B) Cesalpilaceae 34.94±0.40 68.03±1.90 95.33±1.70 
Terminalia glaucescens Planch.ex benth.  Combretaceae 22.41±0.00 59.33±0.70 74.58±1.11 
Ipomea batatas (Lin.) Lam  Convolvulaceae 35.51±0.99 40.14±0.00 50.97±1.40 
Kalonchoe crenata (Andr.) Haw. Crasulaceae 45.84±0.15 62.13±0.00 69.93±0.45 
Alchornea laxiflora (benth.) Pax & K.H.  Euphorbiaceae 58.40±0.40 85.61±0.40 95.60±0.59 
Manihot esculenta Crantz Euphorbiaceae 2.41±0.57 10.69±0.12 29.45±0.15 
Crotalaria lachnophora Hochst.ex A.R  Fabaceae 0.43±0.60 21.36±1.07 54.32±0.40 
Erythrina senegalensis D.C.  Fabaceae 54.48±0.18 95.43±1.36 98.53±0.00 
Harungana madagascariensis Lam. Hypericaceae 7.18±0.42 17.43±0.30 47.48±0.12 
Gladiolus dalenii Van Geel  Iridaceae -0.19±0.27 3.55±0.15 7.29± 0.57 
Occimum Gratissimum Lin. Labieae 11.99±0.30 25.44±0.71 49.42±0.71 
Persea americana Mill.  (L) Lauraceae 3.47±1.29 17.81±0.33 44.05±0.00 
Persea americana Mill.  (B) Lauraceae 0.00±0.00 16.98±1.42 35.54±1.43 
Anthocleista schweinfurthii Gil. Loganiaceae 37.99±0.30 51.96±0.00 57.57±0.44 
Gosypium barbadense (Mac fedyen) J.B.H. Malvaceae 11.96±1.17 19.47±0.16 40.52±1.01 



















Table 2 (continued): Inhibition percentages of carbonyl-group formation of different plants extracts 
 
Entada africana (Guill. et Pers.)  Mimosaceae 50.00±0.71 71.25±0.83 79.55±0.42 
Ficus exasperata Vahl.  Moraceae 17.22±1.01 28.84±0.00 39.56±0.58 
Ficus sp.  Moraceae 27.60±1.20 34.71±0.16 51.39±0.60 
Musa sapientum Lin.  Musaceae 6.99±0.45 25.42±0.42 34.13±0.42 
Eucalyptus sp.   Myrtaceae 58.48±0.30 29.37±2.93 12.95±0.82 
Psidium guayava Lin.  Myrtaceae 17.61±1.32 54.64±0.29 83.72±1.17 
Olax subscorpioideae Oliv.  Olacaceae 13.33±0.33 31.66±0.30 39.12±2.76 
Cymbopogon citratus ( D.C.) Stapf  poaceae 19.12±0.72 26.82±1.56 40.08±0.30 
Melinis minutiflora P. Bearw  Poaceae 5.60±0.40 64.00±1.90 96.92±2.46 
Coffea arabica Lin.  Rubiaceae 11.03±0.35 18.03±0.17 36.45±0.00 
Coffea robusta Lin.  Rubiaceae 29.37±0.00 45.98±0.48 45.80±0.00 
Nauclea latifolia Sm.  Rubiaceae 48.30±0.57 51.89±0.00 70.96±1.54 
Citrus aurantifolia Swingle  Rutaceae 14.90±1.00 38.22±3.38 47.77±0.30 
Citrus sinensis L. ( Osbeck ) Rutaceae 20.65±1.44 29.86±1.00 45.35±1.44 
Solanum acaleastrum Dunal  Solanaceae 2.19±0.51 12.07±1.12 25.23±0.34 
Trema orientalis Lour.  Ulmaceae 13.80±0.88 21.63±1.44 36.49±0.89 
Costus afer Ker .Gawl  Zingiberaceae 36.00±1.36 49.38±0.47 57.87±0.44 
Curcuma longa Lin.  Zingiberaceae 95.31±0.52 99.57 ± 0.00 100.00 ± 0.00 
 
1-Initiation mode of BSA oxidation, Data are given as mean ± SD of two experiments; L = Leaves;      B = Stem 
bark 





Table 3: Computed IC50 (µg/mL) of microsomal lipid oxidation and protein oxidation by some plant extracts.   
Microsomal lipid peroxidation Protein oxidation Species Family 
Non-enzymatical Enzymatical  
Control silymarine  5.5 ± 1.98 22.70 ± 3.34 10.43 ± 2.39 
Mangifera indica Anacardiaceae 69.84 ± 0.70 51.70 ± 2.83 3.33±0.22 
Annona senegalensis Annonaceae NC NC 16.21±1.05 
Enantia chlorantha Apocynaceae 197.16 ± 3.85 NC 108.28±1.00 
Voacanga africana Apocynaceae < 10 < 10 79.91±0.90 
Aspilia Africana Asteraceae NC 53.91 ± 2.26 4.69±1.90 
Bidens pilosa Asteraceae 194.00 ± 9.07 190.91 ± 071 NC 
Chrysanthellum americanum Asteraceae NC NC 6.24±0.37 
Spilanthes filicaulis Asteraceae 239.58 ± 8.05 NC NC 
Vernonia amygdalina Asteraceae NC NC 45.31±1.88 
Carica papaya Caricaceae NC NC 25.44±1.73 
Senna alata Cesalpiniaceae 23.86 ± 1.03 11.57 ± 0.26 2.83±0.39 
Piliostigma thonningii (bark) Cesalpiniaceae 26.13 ± 2.66 28.46 ± 4.04 23.18±0.93 
Piliostigma thonningii (leaves) Cesalpiniaceae 31.39 ± 9.45 37.14 ± 0.55 4.27±0.37 
Terminalia glaucescens Combretaceae NC NC 53.72±0.03 
Kalonchoe crenata Crasulaceae 97.96 ± 0.97 125.25 ± 6.99 17.37±0.00 
Alchornea laxiflora Euphorbiaceae 6.95 ± 4.31 21.64 ± 1.15 6.43 ±0.18 
Crotalaria lachnophora Fabaceae 25.62 ± 0.50 24.79 ± 2.93 189.92 ±7.76 
Erythrina senegalensis Fabaceae 33.11 ± 3.78 31.75 ± 3.65 8.57±0.23 
Harungana madagascariensis Hypericaceae 48.35 ± 1.37 33.28 ± 0.78 NC 
Occimum gratissimum Labieae 77.75 ± 1.44 NC NC 
Anthocleista schweinfurthii Loganiaceae NC NC 67.09±2.72 
Gossypium Barbadense Malvaceae 114.80 ± 3.87 NC NC 
Khaya grandifoliola Meliaceae 81.70 ± 3.30 102.04 ± 2.52 42.04±0.16 
Entada Africana Mimosaceae 50.67 ± 0.46 18.33 ± 0.76 9.85±0.66 
Eucalyptus sp. Myrtaceae 8.14 ± 0.06 31.33 ± 1.45 NC 
Psidium guyava Myrtaceae NC NC 53.20±2.55 
Melinis minutiflora Poaceae 27.42 ± 297 71.29 ± 2.59 54.93±3.25 
Nauclea latifolia Rubiaceae NC NC 17.62±1.41 
Citrus aurantifolia Rutaceae 190.48 ± 6.24 NC NC 
Citrus sinensis Rutaceae 45.01 ± 0.49 NC NC 
Costus afer Zingiberaceae 151.33 ± 6.42 NC 80.43±0.76 
Curcuma longa Zingiberaceae 8.39 ± 1.25 < 10 < 10 
Values are mean ± SD of two experiments  
NC: Values not computed because of the low inhibition percentages obtained with the highest dose of extract 
during the test (< 50%) 
 





Table 4 : Phytochemical composition of some selected active plant extracts 
 
 
   Classes of compounds 
Families &Species 






















































































































































































































































Table 4 (continued): Phytochemical composition of some selected active plant extracts 
 
   Classes of compounds 
Families &Species 



























































































































































 (+) positive test for the class of compounds 
(-) Negative test for the class of compounds 





on Curcuma longa and Erythrina senegalensis. However, in extracts from Enantia chlorantha and Voacanga 
africana which also inhibited both studied biochemical phenomena the presence of alkaloids was also 
demonstrated. 
Since protein degradation and lipid peroxidation seem to occur by distinct mechanisms (Davies and 
Goldberg, 1986), it may be suggested that the above 15 plant extracts have strong lipid and protein oxidation 
inhibitory potency. Therefore, these plant species may be a good source of medicines against diseases in which 
lipids and proteins oxidation are involved such as toxic hepatitis. Further in vitro and in vivo studies on some of 
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